1. Home
  2. IHG vs NBIX Comparison

IHG vs NBIX Comparison

Compare IHG & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intercontinental Hotels Group

IHG

Intercontinental Hotels Group

HOLD

Current Price

$134.45

Market Cap

17.0B

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$155.41

Market Cap

14.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHG
NBIX
Founded
1777
1992
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.0B
14.4B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
IHG
NBIX
Price
$134.45
$155.41
Analyst Decision
Sell
Strong Buy
Analyst Count
2
18
Target Price
N/A
$172.33
AVG Volume (30 Days)
149.3K
963.8K
Earning Date
01-01-0001
10-28-2025
Dividend Yield
1.25%
N/A
EPS Growth
21.99
12.44
EPS
4.70
4.19
Revenue
$5,120,000,000.00
$2,682,700,000.00
Revenue This Year
N/A
$23.76
Revenue Next Year
$6.21
$18.01
P/E Ratio
$28.68
$36.68
Revenue Growth
33.89
19.61
52 Week Low
$94.78
$84.23
52 Week High
$137.73
$157.67

Technical Indicators

Market Signals
Indicator
IHG
NBIX
Relative Strength Index (RSI) 58.92 64.98
Support Level $132.36 $150.26
Resistance Level $137.73 $154.35
Average True Range (ATR) 2.03 4.16
MACD 0.29 1.08
Stochastic Oscillator 73.45 94.02

Price Performance

Historical Comparison
IHG
NBIX

About IHG Intercontinental Hotels Group

InterContinental Hotels Group operates 987,000 rooms across 19 brands addressing the midscale through luxury segments, as of Dec. 31, 2024. Holiday Inn and Holiday Inn Express constitute the largest brand, while Hotel Indigo, Even, Hualuxe, Kimpton, and Voco are newer lifestyle brands experiencing strong demand. The company launched a midscale brand, Avid, in 2017 and closed on a 51% stake in Regent Hotels in 2018. It acquired Six Senses in 2019 and launched another midscale brand, Garner, in 2023. Managed and franchised represent 99% of total rooms. As of Dec. 31, 2024, the Americas represented 53% of total rooms, with Greater China accounting for 20% and Europe, Asia, the Middle East, and Africa making up 27%.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: